Format

Send to

Choose Destination
Life Sci. 2018 Aug 15;207:166-171. doi: 10.1016/j.lfs.2018.06.007. Epub 2018 Jun 6.

Association of polymorphisms of leptin, leptin receptor and apelin receptor genes with susceptibility to coronary artery disease and hypertension.

Author information

1
Endocrinology and Metabolism Research Center, Institute of Basic and Clinical Physiology Sciences, Kerman University of Medical Sciences, Kerman, Iran; Department of Biochemistry, Faculty of Medicine, Kerman University of Medical Sciences, Kerman, Iran.
2
Cardiovascular Research Center, Department of Cardiology, Faculty of Medicine, Kerman University of Medical Sciences, Kerman, Iran.
3
Department of Biochemistry, Faculty of Medicine, Kerman University of Medical Sciences, Kerman, Iran.
4
Physiology Research Center, Institute of Basic and Clinical Physiology Sciences, Kerman University of Medical Sciences, Kerman, Iran.
5
Department of Biochemistry, Faculty of Medicine, Kerman University of Medical Sciences, Kerman, Iran; Neuroscience Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran. Electronic address: gh_asadi@kmu.ac.ir.

Abstract

AIMS:

Apelin and leptin are factors which have a potential physiological and pathological role in cardiovascular homoeostasis. Apelin receptor (APLNR), leptin receptor (LEPR) and leptin variants may affect the vascular tone in heart or peripheral circulation, thereby predisposing patients to hypertension and coronary artery disease (CAD). The aim of the present study was to evaluate four single nucleotide polymorphisms (SNPs) of APLNR genes (rs11544374 and rs948847), LEPR (rs1137101) and leptin (rs7799039) gene in patients with CAD and hypertension.

MATERIALS AND METHODS:

This case-control study was carried out on 286 CAD-suspected patients. The participants were divided into four subgroups including: CAD patients with no hypertension (H-CAD+), hypertensive patients with no CAD (H+CAD-), CAD patients with hypertension (H+CAD+) and non-hypertensive non-CAD subjects as control group (H-CAD-). Genomic DNA from whole blood was extracted and four SNPs were assessed using PCR-RFLP.

KEY FINDINGS:

A significant difference was found in the genotype frequency of APLNR rs11544374 gene in H+CAD+ and H-CAD+ groups compared to control subjects (P < 0.001 for both comparisons). Regarding the rs1137101, the prevalence of A allele compared to G allele was significantly different among the four groups (P = 0.02). Results of multinomial regression analysis indicated that G allele carriers in the recessive genetic model (AA vs. AG + GG) of rs11544374 had a significantly protective effect compared to H-CAD+ and H+CAD+after adjustment (OR = 0.12; 95% CI = 0.02-0.61; P = 0.01 and OR = 0.40; 95% CI = 0.17-0.98; P = 0.04, respectively).

SIGNIFICANCE:

The findings of present study revealed that the APLNR rs11544374 gene polymorphism might serve as predisposing factor in CAD.

KEYWORDS:

Apelin receptor; Coronary artery disease; Hypertension; Leptin; Polymorphism, SNP

PMID:
29883719
DOI:
10.1016/j.lfs.2018.06.007
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center